Repurposing Niflumic Acid-Loaded PEGylated Cerosomes for Topical Solid Ehrlich’s Carcinoma Management via EGFR/ERK/miR-21 Signaling Pathway Modulation
Authors:
- Mona M. MostafaMMMona M. Mostafa
- Shaimaa MosallamSMShaimaa Mosallam
- Mai M. EltaweelMEMai M. Eltaweel
- Maha M. AminMAMaha M. Amin
- Jawaher Abdullah AlamoudiJAJawaher Abdullah Alamoudi
- Heba Mohammed Refat M. SelimHSHeba Mohammed Refat M. Selim
- Mira Magdy WilliamMWMira Magdy William
- Shady M. Abd El-HalimSEShady M. Abd El-Halim
Open Access
- 7 September 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1125
Abstract
Background/Objectives: Repurposing existing drugs may represent a promising strategy for effective cancer therapy. This study was the first to investigate the augmented antitumor therapeutic effect achieved by co-incorporating the NSAID Niflumic acid (NIF) with ceramides into PEGylated cerosomes (NIF-loaded PEG-CERs) in a novel platform that targets specifically the MAPK-ERK signaling pathway and miR-21-5p modulation. Methods: The prepared formulae were statistically optimized utilizing a full factorial design and the optimal formula (C5) was further incorporated into a topical gel and evaluated for ex vivo rat skin permeation, and tested in vivo in a subcutaneous solid Ehrlich carcinoma (SEC) mice model. Results: The optimal formula (C5) showed tubular elongated morphology with higher EE% (96.71 ± 0.0), lower vesicular size (VS) and PDI values, 292.95 ± 0.78 nm and 0.47 ± 0.0 respectively. A high ZP value (−37.5 ± 0.57 mV) was in accordance with stability results showing good stability of the optimal formula (C5). Permeability studies exhibited 2.02-fold higher skin permeation compared to pure NIF gel. A significant decrease in tumor volume and marked improvement in survival rate in SEC mice were confirmed by downregulation of EGFR, ERK1, ERK2, and miR-21-5p expression. Furthermore, an increase in total antioxidant capacity and caspase-3 levels was observed, accompanied by significant suppression in cyclin D1, MMP-2, COX-2, and MDA levels. Finally, histopathological analysis revealed the superior antitumor effect of C5 gel together with immunohistochemical assay showing the lowest BCL-2-positive staining, indicating the restoration of physiological apoptotic balance. Conclusions: Based on the previous findings, NIF-loaded PEG-CERs offer augmented therapeutic potential for efficient topical skin cancer management in an SEC mice model.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University (PNURSP2026R340)
This publication has 154 references indexed in Scilit:
- A phase I study of the ceramide nanoliposome in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2023
- miR‐21‐5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2CFEBS Open Bio, 2020
- Cyclooxygenase‐2 in cancer: A reviewJournal of Cellular Physiology, 2018
- Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cellsMolecular and Cellular Biochemistry, 2018
- Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic painInflammopharmacology, 2016
- Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinomaMolecular Biology Reports, 2016
- Effect of polyethylene glycol-2000 on amino acid surfactant-based vesiclesColloid and Polymer Science, 2014
- Ceramide-Induced Transbilayer (Flip-Flop) Lipid Movement in Membranes2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Determination of critical micelle concentration (CMC) of nonionic surfactants by donor‐acceptor interaction with lodine and correlation of CMC with hydrophile‐lipophile balance and other parameters of the surfactantsJournal of Surfactants and Detergents, 2001